SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U201. A total of 36 filers reported holding SYNTHETIC BIOLOGICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $8,000 | +60.0% | 39,345 | +109.5% | 0.00% | – |
| Q1 2022 | $5,000 | -50.0% | 18,777 | -14.6% | 0.00% | – |
| Q3 2021 | $10,000 | -16.7% | 21,997 | -30.0% | 0.00% | – |
| Q4 2020 | $12,000 | -84.8% | 31,410 | -87.2% | 0.00% | – |
| Q1 2020 | $79,000 | +618.2% | 245,896 | +884.8% | 0.00% | – |
| Q3 2019 | $11,000 | -38.9% | 24,969 | -17.6% | 0.00% | – |
| Q2 2019 | $18,000 | +125.0% | 30,297 | +146.1% | 0.00% | – |
| Q1 2019 | $8,000 | – | 12,312 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 903,741 | $497,000 | 0.62% |
| Alyeska Investment Group, L.P. | 5,000,000 | $2,750,000 | 0.04% |
| WEDBUSH SECURITIES INC | 97,957 | $54,000 | 0.01% |
| SCOPUS ASSET MANAGEMENT, L.P. | 225,000 | $124,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 60,000 | $33,000 | 0.00% |
| 683 Capital Management, LLC | 42,858 | $24,000 | 0.00% |
| UBS Group AG | 600 | $0 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 1 | $1,000 | 0.00% |
| Advisor Group, Inc. | 421 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 316 | $0 | 0.00% |